Inflammatory gene expression associates with hepatitis B virus cccDNA- but not integrant-derived transcripts in HBeAg negative disease

Inflammatory gene expression associates with hepatitis B virus cccDNA- but not integrant-derived transcripts in HBeAg negative disease

Chronic hepatitis B virus (HBV) infection is a global health problem that presents as a spectrum of liver disease, reflecting an interplay between the virus and the host immune system. HBV genomes exist as episomal covalently closed circular DNA (cccDNA) or chromosomal integrants. The relative contr...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Magri, A, Harris, JM, D'Arienzo, V, Minisini, R, Jühling, F, Wing, PAC, Rapetti, R, Leutner, M, Testoni, B, Baumert, TF, Zoulim, F, Balfe, P, Pirisi, M, McKeating, JA
Natura:	Journal article
Lingua:	English
Pubblicazione:	MDPI 2022

Documenti analoghi

Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease
di: Andrea Magri, et al.
Pubblicazione: (2022-05-01)

Gene Editing Technologies to Target HBV cccDNA
di: Maria Guadalupe Martinez, et al.
Pubblicazione: (2022-11-01)

CTCF regulates hepatitis B virus cccDNA chromatin topology
di: Dobrica, MO, et al.
Pubblicazione: (2023)

CTCF regulates hepatitis B virus cccDNA chromatin topology
di: Dobrica, MO, et al.
Pubblicazione: (2024)

A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis
di: Wing, P, et al.
Pubblicazione: (2019)

Estimation of hepatitis B virus cccDNA persistence in chronic infection using within-host evolutionary rates
di: Lythgoe, KA, et al.
Pubblicazione: (2020)

Mechanism of Hepatitis B Virus cccDNA Formation
di: Lei Wei, et al.
Pubblicazione: (2021-07-01)

Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α
di: Kaimin Song, et al.
Pubblicazione: (2025-02-01)

Is the function of the HBeAg really unknown?
di: David R. Milich
Pubblicazione: (2019-09-01)

Mathematical investigation of HBeAg seroclearance
di: Sarah Kadelka, et al.
Pubblicazione: (2019-08-01)

Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels
di: Ko, C, et al.
Pubblicazione: (2018)

Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis B.
di: Thilde Nordmann Winther, et al.
Pubblicazione: (2013-01-01)

HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients
di: Guangjun Song, et al.
Pubblicazione: (2023-11-01)

Manifestations of perihepatic lymph nodes in acute flare of chronic hepatitis B: association with HBeAg status and with HBeAg seroconversion.
di: Yen-Ling Ko, et al.
Pubblicazione: (2015-01-01)

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
di: Xiaomei Wang, et al.
Pubblicazione: (2020-10-01)

Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.
di: Kouichi Kitamura, et al.
Pubblicazione: (2018-06-01)

Asiatic acid inhibits HBV cccDNA transcription by promoting HBx degradation
di: Ranran Li, et al.
Pubblicazione: (2024-10-01)

Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B
di: D S Kostyushev, et al.
Pubblicazione: (2017-11-01)

A novel nomogram for predicting HBeAg seroclearance in HBeAg-positive chronic hepatitis B patients treated with nucleos(t)ide analogues
di: Yan Gu, et al.
Pubblicazione: (2024-01-01)

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
di: Cheng-Yuan Peng, et al.
Pubblicazione: (2015-04-01)

cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
di: Patricia Gita Naully, et al.
Pubblicazione: (2025-01-01)

Mechanisms of Hepatitis B Virus cccDNA and Minichromosome Formation and HBV Gene Transcription
di: Andoni Gómez-Moreno, et al.
Pubblicazione: (2024-04-01)

Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors
di: Phuong Thi Bich Doan, et al.
Pubblicazione: (2023-05-01)

Lamivudine therapy in HBeAg negative chronic hepatitis B patients
di: E. Guclu, et al.
Pubblicazione: (2014-04-01)

HBeAg negative chronic hepatitis B in South Asia
di: Ananta Shrestha, et al.
Pubblicazione: (2016-11-01)

Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markers
di: Kim, KS, et al.
Pubblicazione: (2025)

HBV cccDNA: The Molecular Reservoir of Hepatitis B Persistence and Challenges to Achieve Viral Eradication
di: André Boonstra, et al.
Pubblicazione: (2025-01-01)

Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
di: Wei He, et al.
Pubblicazione: (2024-12-01)

IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
di: Gianna Aurora Palumbo, et al.
Pubblicazione: (2015-01-01)

Hepatitis B virus cccDNA is formed through distinct repair processes of each strand
di: Lei Wei, et al.
Pubblicazione: (2021-03-01)

Envelope antibody HBeIgG and HBV DNA in HBeAg-seronegative young adults in Nigeria
di: Mathew Folaranmi Olaniyan, et al.
Pubblicazione: (2023-09-01)

Circadian control of hepatitis B virus replication
di: Zhuang, X, et al.
Pubblicazione: (2021)

A PCR assay to quantify patterns of HBV transcription
di: D'Arienzo, V, et al.
Pubblicazione: (2019)

DNA Sensor ABCF1 Phase Separates With cccDNA to Inhibit Hepatitis B Virus Replication
di: Caiyue Ren, et al.
Pubblicazione: (2024-12-01)

Early Steps of Hepatitis B Life Cycle: From Capsid Nuclear Import to cccDNA Formation
di: João Diogo Dias, et al.
Pubblicazione: (2021-04-01)

cccDNA-Targeted Drug Screen Reveals a Class of Antihistamines as Suppressors of HBV Genome Levels
di: Ee Chee Ren, et al.
Pubblicazione: (2023-09-01)

Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy
di: Michel Bazinet, et al.
Pubblicazione: (2021-11-01)

Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 InteractionSummary
di: Kazuma Sekiba, et al.
Pubblicazione: (2019-01-01)

Correction: IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
di: Gianna Aurora Palumbo, et al.
Pubblicazione: (2015-01-01)

Baseline value of intrahepatic HBV DNA over cccDNA predicts patient’s response to interferon therapy
di: Di Mu, et al.
Pubblicazione: (2017-07-01)